FAS and neoplasm: Tumor cell signaling competency through innate inflammatory response pathways, such as interferon (IFN)/JAK/STAT, NF-κB, Fas and antigen presentation, has been shown to be essential for immunotherapy efficacy in the experimental and clinical settings27–32.